Synthetic inhibitor leads of human tropomyosin receptor kinase A (hTrkA)
Keyword(s):
New hTrkA kinase domain type 2 inhibitors and mixed type 1/type 2 inhibitor leads disclosed here offers a differential starting point to investigate the disease pathophysiology.
2016 ◽
Vol 34
(15_suppl)
◽
pp. e16126-e16126
Keyword(s):
2011 ◽
Vol 143
(1-2)
◽
pp. 20-26
◽
Keyword(s):
2003 ◽
Vol 71
(11)
◽
pp. 6615-6619
◽
Keyword(s):
2020 ◽
Vol 152
◽
pp. 61-73
◽
1996 ◽
Vol 62
(4)
◽
pp. 431-442
◽